Skip to main content

Syndicate contentU.S. Food and Drug Administration

Investigation of contaminated heparin syringes highlights medication safety issues

An outbreak of bloodstream infections appears to have been caused by the contamination of pre-filled heparin and saline syringes made by a single company, according to a report in the October 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Vaccinating boys against human papillomavirus not cost-effective

Boston, MA -- Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer. Current guidelines prioritize HPV vaccination of pre-adolescent girls, which has been shown to be cost-effective in previous studies, but the value of vaccinating boys in the United States has been unclear.

Cocaine vaccine may help some reduce drug use

A vaccine to treat cocaine dependence appears to reduce use of the drug in a subgroup of individuals who attain high anticocaine antibody levels in response, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Designing drugs and their antidotes together improves patient care

DURHAM, N.C. -- Imagine a surgical patient on a blood-thinning drug who starts bleeding more than expected, and an antidote that works immediately -- because the blood thinner and antidote were designed to work together.

Mount Sinai leads large multicenter study finding evidence that a drug might slow Parkinson's

Following one of the largest studies ever conducted in Parkinson's disease (PD), researchers at Mount Sinai School of Medicine report today in The New England Journal of Medicine that rasagiline, a drug currently used to treat the symptoms of PD, may also slow the rate of disease progression.

Nationwide study examines youth access to indoor tanning

Many indoor tanning businesses require parental consent for teenagers to use their facilities, but most would allow young tanners more than the government-recommended amount of exposure during the first week, according to a report in the September issue of Archives of Dermatology, one of the JAMA/Archives journals.

Study shows common pain cream could protect heart during attack

CINCINNATI -- New research from the University of Cincinnati (UC) shows that a common, over-the-counter pain salve rubbed on the skin during a heart attack could serve as a cardiac-protectant, preventing or reducing damage to the heart while interventions are administered.

These findings are published in the Sept. 14 edition of the journal Circulation.

New 'adjuvant' could hold future of vaccine development

CORVALLIS, Ore. -- Scientists at Oregon State University have developed a new "adjuvant" that could allow the creation of important new vaccines, possibly become a universal vaccine carrier and help medical experts tackle many diseases more effectively.

Safe seed: Researchers yielding good results on food cotton in field

Field trials of a new cotton are verifying previous lab and greenhouse studies indicating the crop could become a source of protein for millions of malnourished people in the world.

The cotton was engineered so that the toxic gossypol is reduced to tolerable levels in the high-protein seed but remain at higher levels in the rest of the plant to ward off pests and disease.

Avastin dramatically improves response, survival in deadly recurrrent glioblastomas

The targeted therapy Avastin, alone and in combination with the chemotherapy drug CPT-11, significantly increased response rates, progression-free survival times and survival rates in patients with a deadly form of brain cancer that had recurred.

Stuy in NEJM: New therapy prevents heart failure

Patients who had a cardiac resynchronization device combined with a defibrillator (CRT-D) implanted had a 34 percent reduction in their risk of death or heart failure when compared to patients receiving only an implanted cardiac defibrillator (ICD), according to a landmark study published online today in the New England Journal of Medicine and presented today at the European Society of C

Scientists help explain effects of ancient Chinese herbal formulas on heart health

New research at The University of Texas Health Science Center at Houston suggests that ancient Chinese herbal formulas used primarily for cardiovascular indications including heart disease may produce large amounts of artery-widening nitric oxide.

Stanford researchers call for drug labels to disclose lack of comparison with existing medications

STANFORD, Calif. -- The labeling information that comes with prescription drugs tells you what's known about the medication, but researchers from the Stanford University School of Medicine think it's high time that the labeling tell you what isn't known.

Jefferson Headache Center study shows novel, orally inhaled migraine therapy effective

PHILADELPHIA -- A new study conducted at the Jefferson Headache Center at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania shows an investigational, orally-inhaled therapy is effective in treating migraines.

Case studies: Dietary supplements with steroids pose health danger

DETROIT -- Three cases of patients suffering from the adverse affects of steroid-enriched dietary supplements have been reported by researchers at Henry Ford Hospital.

The cases, which include patients with liver injury and renal failure, are discussed in the current issue of The Journal of Clinical Gastroenterology.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes